Stock Markets

Daily coverage of equity markets, sectors, and major indices.

In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.

Articles

3,909 total articles

Citi Lowers Nordex to Neutral Citing Rich Valuation After Strong 2025 Rally

Citi Lowers Nordex to Neutral Citing Rich Valuation After Strong 2025 Rally

Citi Research has downgraded Nordex SE (ETR:NDXG) to "neutral" from a prior recommendation, pointing to valuation concerns even as it expects earnings to exceed consensus. The German wind-turbine maker has logged a powerful 2025 rally and robust order momentum, but Citi says current multiples - roughly 15x 2027 P/E and 8x EV/EBITA on its forecasts …

Alibaba Introduces RynnBrain AI to Enable Robots to Perceive and Manipulate the Physical World

Alibaba Introduces RynnBrain AI to Enable Robots to Perceive and Manipulate the Physical World

Alibaba on Tuesday introduced RynnBrain, an artificial intelligence model created to help robots interpret their physical environment and perform object-level tasks. A DAMO Academy demonstration shows a robot identifying fruit and placing it in a basket. The move places Alibaba in competition with firms such as Nvidia, Google DeepMind and those dev…

Morgan Stanley Sticks With Société Générale, Warms to BNP Paribas While Sitting on Crédit Agricole

Morgan Stanley Sticks With Société Générale, Warms to BNP Paribas While Sitting on Crédit Agricole

Morgan Stanley keeps Société Générale at the top of its French bank list, citing stronger-than-expected earnings positioning and reliable capital returns. The broker has grown more constructive on BNP Paribas after management outlined a meaningful cost reduction plan and clearer capital targets, but litigation linked to Sudan restrains a full upgra…

German Auto Sector Faces Investment Exodus and Job Cuts, Lobby Warns

German Auto Sector Faces Investment Exodus and Job Cuts, Lobby Warns

A survey of German automotive suppliers indicates a widespread pullback of investment within Germany, with many companies planning to move, delay, or cancel spending. Industry leaders warn the trend is already affecting employment and could have broader social and political consequences, while urging policy changes at national and EU levels to pres…

UBS Lowers Rating on 1&1 AG to Neutral as Stock Nears Bank Valuation

UBS Lowers Rating on 1&1 AG to Neutral as Stock Nears Bank Valuation

UBS has downgraded 1&1 AG from buy to neutral and slightly reduced its price target to €27.6, arguing that the stock at roughly €26.75 already reflects an expectation of a curtailed mobile network build and a related improvement in free cash flow. The bank outlines a path to positive cash generation if 1&1 limits coverage ambitions, but warns of co…

TSX Futures Edge Up as Markets Brace for Packed U.S. Data Calendar

TSX Futures Edge Up as Markets Brace for Packed U.S. Data Calendar

Futures on Canada’s principal stock gauge inched higher Tuesday as investors positioned ahead of a heavy U.S. economic calendar. Gains in the materials sector, helped by firmer gold, supported the S&P/TSX, while U.S. futures were largely subdued as the market awaited corporate results and rescheduled labor and inflation data. Oil advanced on geopol…

UBS Cuts Ionos Rating, Flags AI Threats and Near-Term Revenue Weakness

UBS Cuts Ionos Rating, Flags AI Threats and Near-Term Revenue Weakness

UBS downgraded German web hosting provider Ionos SE to neutral from buy and reduced its price target to €28 from €40. The brokerage cited persistent risks from AI-enabled website builders that could undermine Ionos' Web Presence and Productivity segment, alongside expectations for slowing revenue growth into 2025 and 2026.

HealthLynked Files for $7 Million Share Offering and Seeks NASDAQ Listing

HealthLynked Files for $7 Million Share Offering and Seeks NASDAQ Listing

HealthLynked Corp. has filed to raise up to $7 million through a public offering of common stock and has applied to list its shares on the NASDAQ Capital Market. The company plans an assumed share price range of $4.00 to $6.00 and currently trades on the OTCQB at $2.75 per share as of February 6, 2026. HealthLynked said the final offering price wil…